Equity Overview
Price & Market Data
Price: $0.106
Daily Change: -$0.00306 / 2.90%
Daily Range: $0 - $0
Market Cap: $6,119,472
Daily Volume: 0
Performance Metrics
1 Week: 12.47%
1 Month: 5.39%
3 Months: -19.86%
6 Months: -27.81%
1 Year: -11.57%
YTD: 3.74%
Details
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.